These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20951098)

  • 1. Glucagon-like peptide 1 and the brain: central actions-central sources?
    Trapp S; Hisadome K
    Auton Neurosci; 2011 Apr; 161(1-2):14-9. PubMed ID: 20951098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a gut-brain axis used by glucagon-like peptide-1 to elicit hyperglycaemia in fish.
    Polakof S; Míguez JM; Soengas JL
    J Neuroendocrinol; 2011 Jun; 23(6):508-18. PubMed ID: 21564347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central GLP-1 actions on energy metabolism.
    Velásquez DA; Beiroa D; Vázquez MJ; Romero A; López M; Diéguez C; Nogueiras R
    Vitam Horm; 2010; 84():303-17. PubMed ID: 21094905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The physiological role of GLP-1 in human: incretin, ileal brake or more?
    Schirra J; Göke B
    Regul Pept; 2005 Jun; 128(2):109-15. PubMed ID: 15780430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide-1 receptor in the brain: role in neuroendocrine control of energy metabolism and treatment target for obesity.
    Lockie SH
    J Neuroendocrinol; 2013 Jul; 25(7):597-604. PubMed ID: 23590331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
    Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
    Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral glucagon-like peptide-1 (GLP-1) and satiation.
    Punjabi M; Arnold M; Geary N; Langhans W; Pacheco-López G
    Physiol Behav; 2011 Nov; 105(1):71-6. PubMed ID: 21371486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anorexigenic effects of GLP-1 and its analogues.
    Gallwitz B
    Handb Exp Pharmacol; 2012; (209):185-207. PubMed ID: 22249815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxyntomodulin reduces expression of glucagon-like peptide 1 receptor in the brainstem of chickens.
    Moghaddam AG; Yaghoobi MM; Jonaidi H; Mahani MT; Sepehri H
    J Anim Physiol Anim Nutr (Berl); 2010 Aug; 94(4):422-8. PubMed ID: 19663977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1 (7-36) amide: a central regulator of satiety and interoceptive stress.
    van Dijk G; Thiele TE
    Neuropeptides; 1999 Oct; 33(5):406-14. PubMed ID: 10657518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central glucagon like peptide-1 delays solid gastric emptying via central CRF and peripheral sympathetic pathway in rats.
    Nakade Y; Tsukamoto K; Pappas TN; Takahashi T
    Brain Res; 2006 Sep; 1111(1):117-21. PubMed ID: 16884700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Food intake-suppressing action of incretin and anti-obesity therapy].
    Nakagawa A; Nishizawa M; Koya D
    Nihon Rinsho; 2011 May; 69(5):826-30. PubMed ID: 21595266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural effects of gut- and brain-derived glucagon-like peptide-1 and its receptor agonist.
    Katsurada K; Yada T
    J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):64-9. PubMed ID: 27186358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide-1(9-36)amide metabolite inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
    Tomas E; Wood JA; Stanojevic V; Habener JF
    Diabetes Obes Metab; 2011 Jan; 13(1):26-33. PubMed ID: 21114600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes.
    Nauck MA
    Horm Metab Res; 2004; 36(11-12):852-8. PubMed ID: 15655719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical endocrinology and metabolism. Glucagon-like peptide-1 and glucagon-like peptide-2.
    Baggio LL; Drucker DJ
    Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):531-54. PubMed ID: 15533774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signaling.
    Ronveaux CC; Tomé D; Raybould HE
    J Nutr; 2015 Apr; 145(4):672-80. PubMed ID: 25833771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous Glucagon-like Peptide-1 Suppresses High-Fat Food Intake by Reducing Synaptic Drive onto Mesolimbic Dopamine Neurons.
    Wang XF; Liu JJ; Xia J; Liu J; Mirabella V; Pang ZP
    Cell Rep; 2015 Aug; 12(5):726-33. PubMed ID: 26212334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis.
    Guan X
    Am J Physiol Regul Integr Comp Physiol; 2014 Sep; 307(6):R585-96. PubMed ID: 24990862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. At the centennial of Michaelis and Menten, competing Michaelis-Menten steps explain effect of GLP-1 on blood-brain transfer and metabolism of glucose.
    Gejl M; Rungby J; Brock B; Gjedde A
    Basic Clin Pharmacol Toxicol; 2014 Aug; 115(2):162-71. PubMed ID: 24684709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.